(Abst.) Rapidly increasing off-label use of rituximab [Rituxan] in Sweden...

« previous next »

Pages: [1]

Author Topic: (Abst.) Rapidly increasing off-label use of rituximab [Rituxan] in Sweden... (Read 84 times)

0 Members and 0 Guests are viewing this topic.

agate

Administrator
Posts: 9480
MS diagnosed 1980
Location: Pacific Northwest

(Abst.) Rapidly increasing off-label use of rituximab [Rituxan] in Sweden...

« on: May 30, 2018, 12:19:55 pm »

From PubMed, May 30, 2018:

https://www.ncbi.nlm.nih.gov/pubmed/29797711

Report to moderator

Logged

MS Speaks--online for 16 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

Pages: [1]

« previous next »

Related Topics

Subject / Started by	Replies	Last post
(AAN abst.) HSV encephalitis associated w/off-label Rituxan use in case of RRMS Started by agate TREATMENTS	0 Replies 128 Views	May 17, 2017, 10:17:02 am by agate
Rituxan (rituximab) Started by agate « 1 2 » TREATMENTS	19 Replies 491 Views	February 27, 2023, 09:36:28 pm by agate
Rituximab (Rituxan)--experimenting with the dosage Started by agate TREATMENTS	0 Replies 81 Views	September 29, 2018, 11:36:07 am by agate
(Abst.) Mitoxantrone in RRMS and rapidly progressing MS... Started by agate NOVANTRONE (mitoxantrone)	0 Replies 57 Views	July 01, 2020, 08:50:35 pm by agate
Rituxan infusion timing, cumulative dose, and hospitalization for COVID-19 in PwMS in Sweden Started by agate TREATMENTS	0 Replies 17 Views	December 16, 2021, 09:29:48 pm by agate